†Process Technology Research Laboratories, Pharmaceutical Technology Division, Daiichi Sankyo Co., Ltd., 1-12-1 Shinomiya, Hiratsuka, Kanagawa 254-0014, Japan.
‡International Research Center for Elements Science, Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan.
J Am Chem Soc. 2015 Jun 10;137(22):7128-34. doi: 10.1021/jacs.5b02277. Epub 2015 May 22.
The first iron-catalyzed enantioselective cross-coupling reaction between an organometallic compound and an organic electrophile is reported. Synthetically versatile racemic α-chloro- and α-bromoalkanoates were coupled with aryl Grignard reagents in the presence of catalytic amounts of an iron salt and a chiral bisphosphine ligand, giving the products in high yields with acceptable and synthetically useful enantioselectivities (er up to 91:9). The produced α-arylalkanoates were readily converted to the corresponding α-arylalkanoic acids with high optical enrichment (er up to >99:1) via simple deprotections/recrystallizations. The results of radical probe experiments are consistent with a mechanism that involves the formation of an alkyl radical intermediate, which undergoes subsequent enantioconvergent arylation in an intermolecular manner. The developed asymmetric coupling offers not only facile and practical access to various chiral α-arylalkanoic acid derivatives, which are of significant pharmaceutical importance, but also a basis of controlling enantioselectivity in an iron-catalyzed organometallic transformation.
首例有机金属化合物与有机亲电试剂的铁催化对映选择性交叉偶联反应被报道。在铁盐和手性双膦配体的催化量存在下,合成多功能的外消旋α-氯代和α-溴代烷酸酯与芳基格氏试剂偶联,以高收率和可接受的合成有用的对映选择性(er 高达 91:9)得到产物。通过简单的脱保护/重结晶,生成的α-芳基烷酸酯很容易转化为相应的具有高光学富集(er 高达>99:1)的α-芳基烷酸。自由基探针实验的结果与涉及形成烷基自由基中间体的机制一致,该中间体以分子间方式经历随后的对映体收敛芳基化。所开发的不对称偶联不仅为具有重要药物意义的各种手性α-芳基烷酸衍生物提供了简便实用的途径,而且为控制铁催化有机金属转化中的对映选择性提供了基础。